Early Language Impairment as an Integral Part of the Cognitive Phenotype in Huntington's Disease
- PMID: 40244831
- PMCID: PMC12172113
- DOI: 10.1002/acn3.70022
Early Language Impairment as an Integral Part of the Cognitive Phenotype in Huntington's Disease
Abstract
Objective: Huntington's disease (HD) speech/language disorders have typically been attributed to motor and executive impairment due to striatal dysfunction. In-depth study of linguistic skills and the role of extrastriatal structures in HD is scarce. This study aimed to explore the profile of language compromise in HD and identify the structural neuroimaging correlates.
Methods: Language and structural correlates were assessed using the Mini Linguistic State Examination (MLSE) in 81 participants (20 HD-ISS 0-1, 40 HD-ISS 2-3 and 21 controls). Clinical and global cognition measures were also obtained. Imaging data included computed gray matter volume (GMV) and cortical thickness (CTh) values extracted from a general linear model with the MLSE. Correlation analyses were performed with the language components of the MLSE. Multivariate regression analyses were used to explore the predictive ability of the language components on GMV and CTh loss.
Results: HD individuals showed impaired MLSE performance (84.5 ± 12.8), particularly in syntax, motor speech, and to a lesser extent, semantics and phonology. Significant associations were found between linguistic performance and the structural integrity of nodes within the temporo-parietal, fronto-parietal, and fronto-striatal lexical-semantic and syntactic networks. Correlation analyses linked motor speech and syntax with predominantly left fronto-striatal GMV and CTh clusters, while semantics had a bilateral fronto-parietal topography. Multivariate regression analyses showed language domains as independent contributing factors of GMV and CTh loss in classical language-related regions.
Interpretation: Language impairment is an integral part of the HD cognitive phenotype, with severity associated with structural disintegration in extensive cortico-subcortical territories involved in language production and processing.
Keywords: Huntington's disease; brain structure; cognitive phenotype; language; neuroimaging.
© 2025 The Author(s). Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Along-Tract Diffusion Alterations in the Dentato-Rubro-Thalamic Tract Correlate With Motor and Cognitive Decline in Huntington's Disease.Hum Brain Mapp. 2025 Aug 1;46(11):e70305. doi: 10.1002/hbm.70305. Hum Brain Mapp. 2025. PMID: 40748199 Free PMC article.
-
Gray matter alterations in Huntington's disease: A meta-analysis of VBM neuroimaging studies.J Neurosci Res. 2024 Jul;102(7):e25366. doi: 10.1002/jnr.25366. J Neurosci Res. 2024. PMID: 38953592
-
Associations between neuropsychological profile and regional brain FDG uptake in progressive supranuclear palsy.J Parkinsons Dis. 2025 Jun;15(4):904-912. doi: 10.1177/1877718X251343080. Epub 2025 May 25. J Parkinsons Dis. 2025. PMID: 40415458
-
Striato-cortical connectivity patterns predict clinical profiles in Huntington's disease.Neuroimage Clin. 2025;46:103788. doi: 10.1016/j.nicl.2025.103788. Epub 2025 Apr 16. Neuroimage Clin. 2025. PMID: 40279872 Free PMC article.
-
Neuroimaging Techniques in Huntington's Disease: A Critical Review.Mov Disord Clin Pract. 2025 May;12(5):561-576. doi: 10.1002/mdc3.70010. Epub 2025 Feb 20. Mov Disord Clin Pract. 2025. PMID: 39976324 Review.
Cited by
-
Update on the Symptomatic Treatment of Huntington's Disease: From Pathophysiology to Clinical Practice.Int J Mol Sci. 2025 Jun 27;26(13):6220. doi: 10.3390/ijms26136220. Int J Mol Sci. 2025. PMID: 40650011 Free PMC article. Review.
References
-
- Ross C. A. and Tabrizi S. J., “Huntington's Disease: From Molecular Pathogenesis to Clinical Treatment,” Lancet Neurology 10, no. 1 (2011): 83–98. - PubMed
-
- Paulsen J. S., Miller A. C., Hayes T., and Shaw E., “Cognitive and Behavioral Changes in Huntington Disease Before Diagnosis,” Handbook of Clinical Neurology 144 (2017): 69–91. - PubMed
-
- Baake V., Reijntjes R. H. A. M., Dumas E. M., et al., “Cognitive Decline in Huntington's Disease Expansion Gene Carriers,” Cortex; A Journal Devoted to the Study of the Nervous System and Behavior 95 (2017): 51–62. - PubMed
-
- Tabrizi S. J., Scahill R. I., Owen G., et al., “Predictors of Phenotypic Progression and Disease Onset in Premanifest and Early‐Stage Huntington's Disease in the TRACK‐HD Study: Analysis of 36‐Month Observational Data,” Lancet Neurology 12, no. 7 (2013): 637–649, 10.1016/S1474-4422(13)70088-7. - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical